| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |